Real-time enrollment status for this lennox-gastaut syndrome clinical trial
Current Status
Recruiting
Checked: April 17, 2026 at 5:12 AM UTC
| NCT Number | NCT06719141 |
| Recruiting Status | Recruiting |
| Condition | Lennox-Gastaut Syndrome |
| Phase | Clinical Trial |
| Target Enrollment | 320 participants |
| Active Locations | 17 sites in the US |
| Sponsor | Longboard Pharmaceuticals |
| Last Updated on CT.gov | April 15, 2026 (2 days ago) |
As of April 17, 2026: Clinical trial NCT06719141 is currently recruiting participants. This clinical trial study for lennox-gastaut syndrome is actively seeking new participants at 17 locations across the United States. The study is sponsored by Longboard Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06719141 is actively recruiting participants as of April 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06719141 was last updated 2 days ago (April 15, 2026). HelloStudys verifies this status automatically.